Inhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposure

Research output: Contribution to journal › Article › Scientific › peer-review

14 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{f39489e6337b40919bb1ff1a38f3b3c0,

title = "Inhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposure",

author = "S Miettinen and S Gr{\`e}nman and T Ylikomi",

year = "2009",

doi = "10.1097/CAD.0b013e328329977f",

language = "English",

volume = "20",

pages = "267--276",

journal = "ANTI-CANCER DRUGS",

issn = "0959-4973",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Inhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposure

AU - Miettinen, S

AU - Grènman, S

AU - Ylikomi, T

PY - 2009

Y1 - 2009

U2 - 10.1097/CAD.0b013e328329977f

DO - 10.1097/CAD.0b013e328329977f

M3 - Article

SN - 0959-4973

VL - 20

SP - 267

EP - 276

JO - ANTI-CANCER DRUGS

JF - ANTI-CANCER DRUGS

IS - 4

ER -